Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 16, 2024 (Week 46)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 15,037 35,826 1,232,781 1,480,620
New England 661 1,128 40,799 48,417
Connecticut 128 296 7,862 11,827
Maine 41 81 2,361 2,651
Massachusetts 378 647 23,584 25,801
New Hampshire - 73 2,125 2,502
Rhode Island 93 389 3,773 4,460
Vermont 21 33 1,094 1,176
Middle Atlantic 2,442 4,247 163,319 179,106
New Jersey 401 748 29,210 31,978
New York (excluding New York City) 693 933 34,660 38,023
New York City 550 1,510 53,712 60,137
Pennsylvania 798 1,167 45,737 48,968
East North Central 1,508 4,573 154,638 202,987
Illinois 122 1,438 38,157 62,676
Indiana 342 698 27,678 30,579
Michigan 214 910 25,587 38,230
Ohio 640 1,153 43,408 49,157
Wisconsin 190 517 19,808 22,345
West North Central 689 1,987 76,918 87,387
Iowa 106 290 10,512 12,356
Kansas 103 288 10,248 12,069
Minnesota 112 486 17,343 19,450
Missouri 330 648 25,543 27,736
Nebraska - 208 6,958 8,272
North Dakota 38 87 2,696 3,079
South Dakota - 108 3,618 4,425
South Atlantic 3,652 12,281 293,957 340,448
Delaware - 199 4,450 5,089
District of Columbia 81 178 5,992 7,562
Florida 1,572 6,933 94,841 100,630
Georgia - 1,476 46,385 65,147
Maryland 666 956 27,671 32,135
North Carolina 2 1,437 48,368 59,414
South Carolina 599 820 29,331 29,522
Virginia 732 911 33,387 37,002
West Virginia - 112 3,532 3,947
East South Central 972 2,748 53,804 95,649
Alabama 537 889 27,873 29,985
Kentucky 351 592 14,415 15,084
Mississippi 84 1,006 11,516 17,539
Tennessee - 834 - 33,041
West South Central 897 4,646 175,586 201,559
Arkansas 175 399 14,032 16,111
Louisiana 363 750 29,847 32,616
Oklahoma 53 407 9,699 17,586
Texas 306 3,262 122,008 135,246
Mountain 1,458 2,691 92,342 104,001
Arizona 377 846 33,182 36,909
Colorado 595 857 21,401 22,969
Idaho 24 124 4,448 5,183
Montana 42 98 2,956 3,292
Nevada 206 344 12,918 14,090
New Mexico 50 229 7,645 10,003
Utah 164 239 8,871 9,911
Wyoming - 47 921 1,644
Pacific 2,758 4,838 181,418 221,066
Alaska 62 125 4,180 4,565
California 1,943 3,800 148,774 172,000
Hawaii - 145 - 5,673
Oregon 316 354 12,378 13,704
Washington 437 562 16,086 25,124
U.S. Territories - 113 667 4,710
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 113 667 4,710
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 3 4 47 46
Total 15,040 35,871 1,233,495 1,485,376
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.